Patents by Inventor Andrey D. MALAKHOV

Andrey D. MALAKHOV has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME
    Publication number: 20230399285
    Abstract: This invention provides illudin derivatives, intermediates, preparation methods, pharmaceutical compositions and uses thereof. Specific examples include novel synthetic routes to prepare illudin derivatives and an illudin derivative having a positive optical rotation, which has therapeutic value.
    Type: Application
    Filed: August 27, 2023
    Publication date: December 14, 2023
    Applicant: LANTERN PHARMA INC.
    Inventors: Gregory J. Tobin, Shawn T. Blumberg, Andrey D. Malakhov
  • Illudin analogs, uses thereof, and methods for synthesizing the same
    Patent number: 11739043
    Abstract: This invention provides illudin derivatives, intermediates, preparation methods, pharmaceutical compositions and uses thereof. Specific examples include novel synthetic routes to prepare illudin derivatives and an illudin derivative having a positive optical rotation, which has therapeutic value.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: August 29, 2023
    Assignee: Lantern Pharma Inc.
    Inventors: Gregory J. Tobin, Shawn T. Blumberg, Andrey D. Malakhov
  • ILLUDIN ANALOGS, USES THEREOF, AND METHODS FOR SYNTHESIZING THE SAME
    Publication number: 20210198191
    Abstract: This invention provides illudin derivatives, intermediates, preparation methods, pharmaceutical compositions and uses thereof. Specific examples include novel synthetic routes to prepare illudin derivatives and an illudin derivative having a positive optical rotation, which has therapeutic value.
    Type: Application
    Filed: March 4, 2021
    Publication date: July 1, 2021
    Inventors: Gregory J. Tobin, Shawn T. Blumberg, Andrey D. Malakhov, Varsin A. Archer
  • Bis-Benzyl-Tetrahydroisoquinoline Derivatives As Therapeutics For Filovirus
    Publication number: 20190275027
    Abstract: Bis-benzyl-tetrahydroisoquinoline analogs that are derivatives of the cyclic products tetrandrine (TETN) and cepharanthine (CEPH). The analogs indicate activity against filovirus infections, including the type species Marburg virus (MARV) and Ebola virus (EBOV).
    Type: Application
    Filed: March 9, 2018
    Publication date: September 12, 2019
    Inventors: William E. BAUTA, Jonathan A. BOHMANN, Michael W. TIDWELL, Andrey D. MALAKHOV, Alejandro SANTILLAN, JR.